 BioXcel Therapeutics, Inc. NASDAQ:BTAI Q3 2022 Earnings Conference Call November 10, 2022 8:30 AM ET Company Participants Vimal Mehta - Chief Executive Officer Founder Matt Wiley - Chief Commercial Officer Richard Steinhart - Chief Financial Officer Rob Risinger - Chief Medical Officer, Neuroscience Vincent ONeill - Chief Medical Officer, Oncology Conference Call Participants Greg Harrison - Bank of America Colin Bristow - UBS Yatin Suneja - Guggenheim Partners Graig Suvannavejh - Mizuho Securities Ram Selvaraju - H.C. Wainwright Corinne Jenkins - Goldman Sachs Operator Good morning, and welcome to the BioXcel Therapeutics Third Quarter 2022 Financial Results Conference Call. 